Drawing for BONESUPPORT

USPTO serial 87150877

BONESUPPORT

Reviewed by CopyMark Law Group

Reg. 5592831Status 702Registered
Filing date
Status date
Registration date
Oct 30, 2018
Examiner
WILKE, JOHN
Law office
Historical data usage

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with BONESUPPORT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Karen Kreider Gaunt

Karen Kreider Gaunt Dinsmore & Shohl LLP255 EAST FIFTH STREET, SUITE 1900CINCINNATI, OH 45202United States

Goods and services

ClassDescriptionStatusFirst use
005Injectable bone substitute material consisting of natural materials; injectable bone material consisting of natural materials for treatment of osteoporotic fractures; injectable bone filler consisting of natural materials for tissue generation; living tissue, cells and/or molecules produced in vitro for replacement and/or support of the function of missing or injured body parts; bone void fillers consisting of natural materials; [ bone fillers consisting of living materials; ] bone void fillers consisting of natural materials; [ bone growth media consisting of biological materials for medical purposes; pharmaceutical products and preparations for the treatment of bone diseases; ] pharmaceutical products and preparations for the treatment of bone fractures; injectable osteoconductive materials consisting of natural materials; injectable radiopaque bone substitute consisting of natural materials; natural bioceramic bone substitutes; bone remodelling materials consisting of natural materials; pharmaceutical preparations for use within [ general surgery, urology, odontology, ] orthopedic surgery *;* [ and cosmetic surgery; ] biological preparations for treatment of fractures, osteoporotic fractures, and bone voids caused by trauma, infection, disease or associated surgery; natural biomaterial for augmentation of bone and tissue for medical purposes; ceramics for medical purposes, namely ceramics for use within general surgery, urology, odontology, orthopedic surgery and cosmetic surgery; biological bone implant materialACTIVE
010[ Hypodermic injectors; medication injectors; ] injection syringes; [ needles for syringes; ] injection device for pharmaceuticals; injectors for medical purposes; apparatus, instruments and equipment for preparing of injectable bone substitute material; apparatus, instruments and equipment for injecting injectable bone substitute material; bone substitutes for surgical use; substitutes for bones; non-biological bone implant material; artificial bone materials; artificial bone materials of ceramics; artificial bone parts to be implanted in natural bones; apparatus, instruments and equipment for preparing and application of pharmaceutical preparations for medical purposes; containers for bone substitutes; mixing instruments for medical purposes; injection instruments as well as instruments for preparing and making the injection easier; instruments and equipment for preparing and application of biological preparations for medical purposes; apparatus, instruments and equipment for preparing and application of biomaterials for medical purposes; apparatus, instruments and equipment for preparing and application of ceramic material for medical purposes; apparatus, instruments and equipment instruments for preparing and application of bone substitute material for medical purposes; apparatus, instruments and equipment instruments for preparing and application of preparations used in surgery, [ urology, odontology, ] orthopaedic [ , and cosmetic ] operations; artificial bone substitutes and bone expanders for odontological, [ cosmetically and ] operative procedures; parts and fittings for the aforementioned goods; biphasic injectable ceramic bone substituteACTIVE
041Education, namely, provision of teaching and training in the field of the development and commercialization of injectable bio-ceramic composites for patients suffering from bone disorders; provision of teaching and training in relation to apparatus, instruments and equipment in connection with injectable bone substitute material; provision of teaching and training in relation to injectable bone substitute material; provision of teaching and training in relation to bone disease and the impact upon bones of various cancers; provision of teaching and training in relation to [ medicine, ] medical techniques, medical technical products and medical services; provision of teaching and training for medical and healthcare professionals in the field of the development and commercialization of injectable bio-ceramic composites for patients suffering from bone disorders; [ provision of teaching and training in relation to osteopathy; ] provision of teaching and training in relation to bone filling and implant services; advisory and consultancy services relating to the aforementionedACTIVE
042Scientific and technological services namely, scientific research, analysis, and testing, in the field of the development and commercialization of injectable bio-ceramic composites for patients suffering from bone disorders and research and design relating thereto; [ medical and pharmacological research and development services; ] analysis of medical and technical research and development; industrial analysis and research services in the field of the development and commercialization of injectable bio-ceramic composites for patients suffering from bone disorders; clinical research in the field of the development and commercialization of injectable bio-ceramic composites for patients suffering from bone disorders; clinical trials [ for others ] relating to the development and commercialization of injectable bio-ceramic composites for patients suffering from bone disorders; conducting clinical trials and research in the field of bone disease; conducting clinical trials and research in the field of for injectable bone substitutes, materials and fillers; design and development of computer software in connection with injectable bone substitute material, injecting bone substitute material, preparing bone substitute material and equipment therefor; information, advisory and consultancy services relating to the aforementioned; development and commercialization of injectable bio-ceramic composites for patients suffering from bone disordersACTIVE
044[ Medical imaging services; medical testing for diagnostic or treatment purposes; ] medical information; [ rental of medical equipment; leasing of medical equipment; medical screening; medical counselling; ] medical consultation; [ charitable services, namely, providing medical services; medical services for the treatment of bone cancer and tumours; medical services for the treatment of bone disease; medical services in connection with injectable bone substitute material; medical services in connection with injecting bone substitute material; diagnostic, medical and treatment services in connection with preparing bone substitute material and equipment therefor; ] advisory and consultancy services relating to the aforementionedACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 19, 2025NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Feb 19, 2025C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Feb 19, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL
Oct 11, 2024E815TEAS SECTION 8 & 15 RECEIVED
Oct 30, 2023REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Oct 30, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 24, 2018DP1B1(B) BASIS DELETED; PROCEED TO REGISTRATION
Sep 24, 2018AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL
Sep 4, 2018IUCNNOTICE OF ALLOWANCE CANCELLED
Sep 4, 2018CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 4, 2018COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 4, 2018D1BRTEAS DELETE 1(B) BASIS RECEIVED
Jul 3, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 8, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 8, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 18, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 2, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Mar 22, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Mar 22, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 22, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 9, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 9, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 9, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 8, 2018ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN
Feb 6, 2018PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY
Jan 22, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Jan 18, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Jan 17, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 17, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 18, 2017GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 18, 2017GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 18, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 14, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Jul 14, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 7, 2017ALIEASSIGNED TO LIE
Jun 4, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 6, 2016GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 6, 2016GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 6, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 6, 2016DOCKASSIGNED TO EXAMINER
Sep 1, 2016MDSMNOTICE OF DESIGN SEARCH CODE E-MAILED
Aug 31, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 29, 2016NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance